129 related articles for article (PubMed ID: 29539609)
1. Impaired Secretion of Glucagon-Like Peptide 1 in Patients with Colorectal Adenoma after an Oral Glucose Load.
Sasaki Y; Abe Y; Takeda H; Nishise S; Yaoita T; Yagi M; Sakuta K; Mizumoto N; Shoji M; Onozato Y; Kawata S; Ueno Y
Digestion; 2018; 97(4):324-332. PubMed ID: 29539609
[TBL] [Abstract][Full Text] [Related]
2. [The changes of gastrointestinal hormones GLP-1, PYY and ghrelin in patients with newly diagnosed type 2 diabetes mellitus].
Cui T; Ren Y; Ma H; Liu SF; Zhang XX; Yu HL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):774-8. PubMed ID: 24325110
[TBL] [Abstract][Full Text] [Related]
3. Impaired secretion of glucagon-like peptide 1 during oral glucose tolerance test in patients with newly diagnosed type 2 diabetes mellitus.
Wang XL; Ye F; Li J; Zhu LY; Feng G; Chang XY; Sun K
Saudi Med J; 2016 Jan; 37(1):48-54. PubMed ID: 26739974
[TBL] [Abstract][Full Text] [Related]
4. Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.
Tura A; Bagger JI; Ferrannini E; Holst JJ; Knop FK; Vilsbøll T; Mari A
Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1123-1129. PubMed ID: 29162361
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1 secretion in women with gestational diabetes mellitus during and after pregnancy.
Lencioni C; Resi V; Romero F; Lupi R; Volpe L; Bertolotto A; Ghio A; Del Prato S; Marchetti P; Di Cianni G
J Endocrinol Invest; 2011 Oct; 34(9):e287-90. PubMed ID: 21666414
[TBL] [Abstract][Full Text] [Related]
6. Patients With Long-QT Syndrome Caused by Impaired
Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
[TBL] [Abstract][Full Text] [Related]
7. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
[TBL] [Abstract][Full Text] [Related]
8. The incretin effect in cats: comparison between oral glucose, lipids, and amino acids.
Gilor C; Graves TK; Gilor S; Ridge TK; Weng HY; Dossin O
Domest Anim Endocrinol; 2011 May; 40(4):205-12. PubMed ID: 21397435
[TBL] [Abstract][Full Text] [Related]
9. Relationship between metabolic syndrome and meal-induced glucagon like peptide-1 response in type 1 diabetic patients1-1.
Blaslov K; Bulum T; Zibar K; Duvnjak L
J Diabetes; 2015 May; 7(3):340-6. PubMed ID: 25042812
[TBL] [Abstract][Full Text] [Related]
10. Chromanol 293B, an inhibitor of KCNQ1 channels, enhances glucose-stimulated insulin secretion and increases glucagon-like peptide-1 level in mice.
Liu L; Wang F; Lu H; Ren X; Zou J
Islets; 2014; 6(4):e962386. PubMed ID: 25437377
[TBL] [Abstract][Full Text] [Related]
11. Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects.
Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
J Clin Endocrinol Metab; 2012 Apr; 97(4):1363-70. PubMed ID: 22319034
[TBL] [Abstract][Full Text] [Related]
12. Hyperinsulinemia, insulin resistance and colorectal adenomas: A meta-analysis.
Yoon YS; Keum N; Zhang X; Cho E; Giovannucci EL
Metabolism; 2015 Oct; 64(10):1324-33. PubMed ID: 26169471
[TBL] [Abstract][Full Text] [Related]
13. Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis.
Calanna S; Piro S; Di Pino A; Maria Zagami R; Urbano F; Purrello F; Maria Rabuazzo A
Obesity (Silver Spring); 2013 Feb; 21(2):320-5. PubMed ID: 23404781
[TBL] [Abstract][Full Text] [Related]
14. Impaired circulating glucagon-like peptide-1 response to oral glucose in women with previous gestational diabetes.
Forbes S; Moonan M; Robinson S; Anyaoku V; Patterson M; Murphy KG; Ghatei MA; Bloom SR; Johnston DG
Clin Endocrinol (Oxf); 2005 Jan; 62(1):51-5. PubMed ID: 15638870
[TBL] [Abstract][Full Text] [Related]
15. Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus.
Cuthbertson J; Patterson S; O'Harte FP; Bell PM
Metabolism; 2011 Jan; 60(1):52-6. PubMed ID: 20152998
[TBL] [Abstract][Full Text] [Related]
16. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
[TBL] [Abstract][Full Text] [Related]
17. The effects of short-term continuous subcutaneous insulin infusion treatment on fasting glucagon-like peptide-1 concentrations in newly diagnosed type 2 diabetes.
Huang X; Li S; Yang M; Fu X; Li H; Yan T; Liu Y; Chen L; Lan L; Li L; Zhong X
Diabetes Res Clin Pract; 2018 Apr; 138():246-252. PubMed ID: 29408704
[TBL] [Abstract][Full Text] [Related]
18. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.
Nauck MA; El-Ouaghlidi A; Gabrys B; Hücking K; Holst JJ; Deacon CF; Gallwitz B; Schmidt WE; Meier JJ
Regul Pept; 2004 Nov; 122(3):209-17. PubMed ID: 15491793
[TBL] [Abstract][Full Text] [Related]
19. Reduced GLP-1 Secretion at 30 Minutes After a 75-g Oral Glucose Load Is Observed in Gestational Diabetes Mellitus: A Prospective Cohort Study.
Sukumar N; Bagias C; Goljan I; Weldeselassie Y; Gharanei S; Tan BK; Holst JJ; Saravanan P
Diabetes; 2018 Dec; 67(12):2650-2656. PubMed ID: 30232211
[TBL] [Abstract][Full Text] [Related]
20. Impaired secretion of active GLP-1 in patients with hypertriglyceridaemia: A novel lipotoxicity paradigm?
Wang X; Liu J; Li C; Zhao M; Liu L; Guan Q; Zhang H; Zhang X; Gao L; Zhao J; Song Y
Diabetes Metab Res Rev; 2018 Feb; 34(2):. PubMed ID: 29135069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
